SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-17-008446
Filing Date
2017-02-13
Accepted
2017-02-13 11:44:54
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a17-3964_3sc13ga.htm SC 13G/A 79369
2 EX-99.1 a17-3964_3ex99d1.htm EX-99.1 7884
  Complete submission text file 0001104659-17-008446.txt   89084
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Subject) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-51477 | Film No.: 17597119
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110
Business Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110 617 772-8500
Tekla Capital Management LLC (Filed by) CIK: 0001300336 (see all company filings)

IRS No.: 010628853 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G/A